Welcome to our dedicated page for Damon SEC filings (Ticker: DMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Damon Inc is rewriting motorcycling, yet its rapid growth, licensing deals, and ZEM credit strategy make its regulatory story anything but simple. If you have ever typed “What does Damon Inc report in their SEC filings?” or searched “Damon Inc SEC filings explained simply,” you know the hunt for HyperDrive cost data or CoPilot R&D spend can take hours.
Stock Titan ends that frustration. Our AI-powered summaries turn a dense Damon Inc annual report 10-K simplified into plain-language insights, surface every Damon Inc quarterly earnings report 10-Q filing, and decode even the most technical 8-K material events explained. Need alerts on Damon Inc insider trading Form 4 transactions? We stream Damon Inc Form 4 insider transactions real-time, so you can track executive stock transactions Form 4 the moment they hit EDGAR. The same engine links each proxy statement executive compensation table to KPIs like battery cost per kWh, while offering Damon Inc earnings report filing analysis that spotlights revenue from HyperDrive licensing.
Professionals use these tools to compare quarter-over-quarter cash burn, monitor ZEM credit sales, and understand Damon Inc SEC documents with AI—without wading through 200 pages. Every filing updates in real time, complete with redline comparisons, searchable text, and one-click downloads. From initial S-1 drafts to definitive 14A proxies, all Damon Inc disclosures live here—already explained.
Damon Inc. reporting persons Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) and Waqas Khatri report beneficial ownership of 45,778 shares of common stock, which are issuable upon exercise of 18,311 warrants. The holdings represent approximately 0.002% of the issuer's outstanding common stock based on 2,450,477,042 shares outstanding as stated by the issuer on May 19, 2025. The issuable shares are subject to a 9.99% beneficial ownership blocker.
The filing states the reporting persons have sole voting and dispositive power over the reported shares and that the securities were acquired and are held in the ordinary course of business. The reported share amounts are prior to adjustment for a reverse stock split effective July 3, 2025.
Damon announces significant changes in its accounting oversight and reveals concerning financial indicators. The company has changed its independent registered public accounting firm from Marcum LLP to CBIZ CPAs following CBIZ's acquisition of Marcum's attest business on November 1, 2024.
Key developments include:
- Marcum's 2024 audit report included a going concern warning about the company's ability to continue operations
- Material weaknesses identified in internal controls over financial reporting, including ineffective monitoring and insufficient controls for financial processing
- Company's stock has been delisted from Nasdaq as of May 20, 2025, now trading on OTC Pink Market under "DMNIF" at $0.0009 per share
- Company is offering 126.9 million units, each comprising one common share and one Series A Warrant, plus additional shares for resale by selling securityholders
These developments signal significant challenges in Damon's financial position and corporate governance, warranting careful investor consideration.
Damon has filed a prospectus supplement updating three previous prospectuses regarding: (1) an offering of 126.9M units (each comprising one common share and one Series A Warrant), (2) resale of 1.01M common shares, and (3) resale of 18.51M common shares.
Key developments include:
- Auditor Change: CBIZ CPAs P.C. replaced Marcum LLP as the independent registered public accounting firm on June 17, 2025, following CBIZ's acquisition of Marcum's attest business
- Going Concern: Marcum's 2024 audit report included a going concern warning
- Material Weaknesses: Identified in internal controls, including ineffective financial reporting processes and lack of personnel with U.S. GAAP expertise
- Trading Status: Delisted from Nasdaq as of May 20, 2025; now trading on OTC Pink Market under "DMNIF" at $0.0009 per share